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The crystal structure of pyroglutamyl peptidase I from Bacillus
amyloliquefaciens reveals a new structure for a cysteine protease
Y Odagaki1,2†, A Hayashi2, K Okada2, K Hirotsu2, T Kabashima3, K Ito3,
T Yoshimoto3, D Tsuru3, M Sato4 and J Clardy1*
Background: The N-terminal pyroglutamyl (pGlu) residue of peptide hormones,
such as thyrotropin-releasing hormone (TRH) and luteinizing hormone releasing
hormone (LH-RH), confers resistance to proteolysis by conventional
aminopeptidases. Specialized pyroglutamyl peptidases (PGPs) are able to
cleave an N-terminal pyroglutamyl residue and thus control hormonal signals.
Until now, no direct or homology-based three-dimensional structure was
available for any PGP.
Results: The crystal structure of pyroglutamyl peptidase I (PGP-I) from Bacillus
amyloliquefaciens has been determined to 1.6 Å resolution. The
crystallographic asymmetric unit of PGP-I is a tetramer of four identical
monomers related by noncrystallographic 222 symmetry. The protein folds into
an α/β globular domain with a hydrophobic core consisting of a twisted β sheet
surrounded by five α helices. The structure allows the function of most of the
conserved residues in the PGP-I family to be identified. The catalytic triad
comprises Cys144, His168 and Glu81.
Conclusions: The catalytic site does not have a conventional oxyanion hole,
although Cys144, the sidechain of Arg91 and the dipole of an α helix could all
stabilize a negative charge. The catalytic site has an S1 pocket lined with
conserved hydrophobic residues to accommodate the pyroglutamyl residue.
Aside from the S1 pocket, there is no clearly defined mainchain substrate-
binding region, consistent with the lack of substrate specificity. Although the
overall structure of PGP-I resembles some other α/β twisted open-sheet
structures, such as purine nucleoside phosphorylase and cutinase, there are
important differences in the location and organization of the active-site residues.
Thus, PGP-I belongs to a new family of cysteine proteases.
Introduction
Some peptides and proteins use an N-terminal pyroglu-
tamyl (pGlu) residue to protect them from proteolytic
attack by aminopeptidases [1]. In humans, thyrotropin-
releasing hormone (TRH; Figure 1) and luteinizing
hormone releasing hormone (LH-RH) have such N-termi-
nal pGlu residues. Both TRH [2,3] and LH-RH [4] are
produced in the hypothalamus and stimulate the produc-
tion of essential hormones in the pituitary gland; protease
resistance is needed to survive the journey from one loca-
tion to the other. TRH controls the thyroid-stimulating
hormone, and LH-RH controls both luteinizing hormone
and follicle-stimulating hormone [5,6]. The strategy of pro-
tecting biologically active peptides with pGlu is wide-
spread, as illustrated by bombesin (a tetradecapeptide from
the skin of reptiles that elicits a strong hypertensive
response in mammals [7]), neurotensin (a tridecapeptide
from mammalian brain that induces hypotension in rats
[8]) and the gastrins (heptadecapeptides that are potent
gastric secretion stimulants [9]). The specialized proteases
that cleave pGlu–X bonds are called pyroglutamyl pepti-
dases (PGPs) and two types of PGP have been described in
the literature. Pyroglutamyl peptidase I (PGP-I, L-pyroglu-
tamyl-peptide hydrolase, EC 3.4.19.3) is a cytosolic cys-
teine protease that degrades a broad spectrum of
pGlu-containing peptides including TRH, LH-RH,
bombesin, neurotensin and gastrins [10,11]. In addition to
its broad spectrum of activity, PGP-I is widely found in
bacteria, plants and animals [10]. Pyroglutamyl peptidase
II (PGP-II, EC 3.4.19.6) is an incompletely characterized
mammalian protein that appears to be a membrane-bound
metalloprotease localized in the synaptosomal membranes
of brain tissue [10,12,13]. PGP-II resembles an enzyme
found in rat serum [14] and, in contrast to the broad speci-
ficity of PGP-I, is highly specific for TRH [15]. 
Recently, Wang et al. addressed the immunoregulatory
effects of local hormonal networks, specifically TRH and
thyroid-stimulating hormone, on intestinal T cells [16].
They suggested that TRH initiates the activation of
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intraepithelial lymphocytes in the intestine, and that insuf-
ficient PGP-I activity could be associated with auto-
immune diseases. 
The purification of PGP-I from several species of the
genus Bacillus and the characterization of its enzymatic
properties have been reported [17]. PGP-I from Bacillus
amyloliquefaciens has been particularly well studied: its
gene has been cloned, sequenced and expressed in
Escherichia coli, and the protein product has been purified.
PGP-I from B. amyloliquefaciens comprises 215 amino acid
residues and has a deduced subunit molecular mass of
23.3 kDa. The protein is most active at pH 6.5 and gel fil-
tration results suggest that the protein occurs in solution as
a homodimer [17]. 
The amino acid sequences of several bacterial PGP-Is
identified from a BLAST [18] search of the SwissProt and
EMBL databases [19] are given in Figure 2. Five amino
acid sequences have been deposited in the EMBL data-
base as PGP-I, although one of these is unpublished.
Another five sequences were found as the result of a
sequence similarity search using PGP-I from B. amylolique-
faciens as the search query. For some of these sequences
no activity or function has been identified, but the high
similarity strongly suggests that they are members of the
PGP-I family. The search revealed no recognizable
homology with any other sequences.
As 4-chloromercuribenzoic acid (PCMB) [20] treatment of
PGP-I leads to loss of activity and 5,5′-dithio(2-nitroben-
zoic acid) (DTNB) titration indicates one accessible cys-
teine residue in the native enzyme, PGP-I has tentatively
been assumed to be a cysteine protease. PGP-I contains
two cysteine residues, Cys68 and Cys144, and Cys144 and
its surrounding residues are completely conserved
(Figure 2). A Cys144→Ser mutant of PGP-I has no
detectable PGP activity, whereas the Cys68→Ser mutant
has wild-type activity [17]. His168 is also completely con-
served, and thus PGP-I was thought to be a cysteine pro-
tease with a Cys-His catalytic diad or Cys-His-Asp/Glu
catalytic triad. 
Cysteine proteases are a very diverse group of enzymes
and at least 20 families have been enumerated [20]. As
members of the different families show little if any recog-
nizable homology, even the sequence order of the cat-
alytic diad or triad varies, the cysteine proteases are
thought to have many separate evolutionary origins [20].
The diversity suggested by the sequence data is rein-
forced by the structural data currently available. Three-
dimensional structures are available for four of the
families. Papain is the archetypal member of the largest
family of well characterized cysteine proteases, which
includes members that are highly specific (glycyl
endopeptidase) and members with broad endopeptidase
(cathepsins K, L and S) and exopeptidase (cathepsins B
and H) activity [20]. The second family of cysteine pro-
teases for which structures are available comprise pro-
teases of the hepatitis virus picornaviral 3C family.
Members of this family have a fold similar to chy-
motrypsin-like serine proteases [21]. The interleukin-1β
converting enzyme (ICE, caspase-1) represents a third
type of cysteine protease with respect to global fold, topol-
ogy and three-dimensional structure [22,23]. Finally, the
adenovirus protease, which is indispensable for the aden-
ovirus life cycle, also has an unique fold and represents
the fourth family [24]. Despite their structural differences,
all of these enzymes rely on a nucleophilic active-site cys-
teine coupled with histidine as a catalytic diad or with his-
tidine and an acidic amino acid as a catalytic triad. In a
recent reclassification [19], PGP-I was included in the Ω
protease family; the three-dimensional structure of an Ω
protease has not been reported. 
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Figure 1
The reaction catalyzed by PGP-I. The choice of TRH as substrate is illustrative as PGP-I cleaves the pGlu–X bond of a wide variety of substrates.
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Figure 2
Sequence alignments of the nine currently
known PGP-I amino acid sequences.
Conserved residues are shown in red and
conservatively substituted residues are in
yellow. Secondary structure classifications for
the B. amyloliquefaciens PGP-I structure are
shown in black beneath the sequences:
β strands are shown as arrows and α helices
as cylinders. The residues of the catalytic triad
are marked by colored symbols above the
sequence alignment — Cys144 (yellow),
His168 (blue) and Glu81 (red) — and these
residues are completely conserved. Interaction
regions between the monomeric subunits of
PGP-I are indicated on the bottom line where
‘C’ indicates an interaction between the A and
C monomers and ‘D’ indicates an interaction
between the A and D monomers. These
residues have close contacts (< 4.0 Å) with
the nearest nonhydrogen atoms of the
adjacent monomer. The sequences used in the
alignment are B. amyloliquefaciens (BACAM)
[17], B. subtilis (BACSU) [31], Streptococcus
pyrogenes (STRPY) [55], Lactococcus lactis
(LACLA) [56], Staphylococcus aureus
(STAAU) [57], Pseudomonas fluorescens
(PSEFL) [58], Pyrococcus horikoshii
(PYRHO) [59], Saccharomyces cerevisiae
(SACCE) [60] and the archaeon Pyrococcus
furisus (PYRFU) [61].
Intratetramer
                                                 
                                                 
                                                 
                                                 
PYRFU
SACCE
PYRHO
PSEFL
STAAU
LACLA
STRPY
BACSU
BACAM
                                                 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
β1 α1 β2
M S K V L V T G F G P Y G V T P V N P A Q L T A E E L D G R T I
M K V L V T G F E P F G G E K I N P T E R I A K D L D G I K I
M K I L L T G F E P F G G D D K N P T M D I V E A L S E
M R I V L L T G F E P F D Q D P V N P S W E A V R Q L D G V Q L
M H I L V T G F A P F D N Q D I N P S W E A V T Q L E N I I
M K I L V T G F D P F G D D K I N P A I E A V K R L P D E I A
M K I L V T G F D P F G G E A I N P A L E A I K K L P A T I H
M R K K V L I T G F D P F D K E T V N P S W E A A K R L N G F E T
M E K K V L L T G F D P F G G E T V N P S W E A V K R L N G A A E
10 20 30
-  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
β3 α2 β4
A G A T V I S R I V P N T F F E S I A A A Q Q A I A E I E P A L V I M L G E Y P G
G D A Q V F G R V L P V V F G K A K E V L E K T L E E I K P D I A I H V G L A P G
R I P E V V G E I L P V S F K R A R E K L L K V L D D V R P D I T I N L G L A P G
G S D V K I V A R R L P C A F A T A G E C L T R L I D E L H P A M V I A T G L G P G
G T H T I D K L K L P T S F K K V D T I I N K T L A S N H Y D V V L A I G Q A G G
G A Q I V K L E I P T K F N V S A D V V K D A I A K E K P D Y V L S I G Q A G G
G A E I K C I E V P T V F Q K S A D V L Q Q H I E S F Q P D A V L C I G Q A G G
E E A I I T A E Q I P T V F R S A L D T L R Q A I Q K H Q P D I V I C V G Q A G G
G P A S I V S E Q V P T V F Y K S L A V L R E A I K K H Q P D I I I C V G Q A G G
40 50 60 70
- C C - - - - D - - D D D - D  - D   - - - - - - - - - - - - - - - - - - - D D -
β5 β6 β7
R S M I T V E R L A Q N V N D C G R Y G L A D C A G R V L V G E P T D P A G P V A Y
R S A I S I E R I A V N A I D A R I P D N E G K K I E D E P I V P G A P T A Y
R T H I S V E R V A V N M I D A R I P D N D G E Q P K D E P I V E G G P A A Y
R S D I S V E R V A I N I N D A R I P D N L G E Q P I D T A V V A D G P A A F
R N A I T P E R V A I N I D D A R I P D N D D F Q P I D Q A I H L D G A P R Y
R F E L T P E R V A I N L D D G R I Q D N A G Y Q P L N H T I H G D D E N A Y
R T G L T P E R V A I N Q D D A R I P D N E G N Q P I D T P I R A D G K A A Y
R M Q I T P E R V A I N L A D A R I P D N E G H Q P I D E E I S P D G P A A Y
R M Q I T P E R V A I N L N E A R I P D N E G N Q P V G E D I S Q G G P A A Y
80 90 100 110
D - - - - - D - - - - - - C - - C C C - - - - D D - - D - - - - - - - -  - - - - -
α3 α4
H A T V P V R A M V L A M R K A G V P A D V S D A A G T F V C N H L M Y G V L H H L
F S T L P I K K I M K K L H E R G I P A Y I S N S A G L Y L C N Y V M Y L S L H H S
F A T I P T R E I V E E M K K N G I P A V L S Y T A G T Y L C N F A M Y L T L H T S
F T T L P I K A M V K A V R E A G I A A S V S Q T A G T F V C N Q V F Y L L Q H A
F S N L P V K A M T Q S V I N Q G L P G A L S N S A G T F V C N H V L Y H L G Y L
F T Q L P I K A M A K A I R E A G V P S A V S N T A G T Y V C N H I F Y Q V Q Y M
F S T L P I K A M V A A I H Q A G L P A S V S N T A G T F V C N H L M Y Q A L Y L
W T R L P V K R M T A K M K E H G I P A A V S Y T A G T F V C N Y L F Y G L M D H
W T G L P I K R I V E E I K K E G I P A A V S Y T A G T F V C N H L F Y G L M D E
120 130 140 150
Structure
- - - - - - - - - - - - - - - - - - C C - C       C - - C C C C - C  - - C -
β8 α5
A Q K G L P V R A G W I H L P C L P S V A A L D H N L G V P S M S V Q T A V
A T K G Y P K M S G F I H V P Y I P E Q I I D K I G K G Q V P P S M C Y E M E L
A T K G Y P K I A G F I H V P Y T P D Q V L E K K N T P S M S L D L E I
L A G S G V R S G F I H V P F L P E Q V A G S Q R P S M A L D A M V
Q D K H Y P H L R F G F I H V P Y I P E Q V V G K S D T P S M P L E A G L
R D K M F P D I K A G F M H I P F L P E Q V V T R P E T P A L S L Q Q I V
V D K Y C P N A K A G F M H I P F M M E Q V V D K P N T A A M N L D D I T
I S R T S P H I R G G F I H I P Y I P Q Q T I D K T A P S L S L D T I V
I S R H H P H I R G G F I H I P Y I P E Q T L Q K S A P S L S L D H I T
160 170 180
- - - - - - - - - - -   - - - - -    - - - D D - - - - -
α6
A G V T A G I E A A I R Q S A D I R E P I P S R L Q I
E A V K V A I E V A L E E L L
K G V E I A I R V A Q S A L H S S Q L R
A G L Q A A V L T A W H T P V D V K E A G G Q V S
T A A I E A I S D H D D L R I A L G T T E
D D V L G I T A A I K A I V S R D G K G D I E T I E G K D H
R G I E A A I F A I V D F K D R S D L K R V G G A T H
R A L R I A A V T A A Q Y D E D V K S P G G T L H
K A L K I A A V T A A V H E D D I E T G G G E L H
190 200 210
Here we describe the X-ray analysis and three-dimen-
sional structure of PGP-I from B. amyloliquefaciens at 1.6 Å
resolution. The monoclinic crystal form has four crystallo-
graphically independent copies of PGP-I in the asymmet-
ric unit, and a self-rotation search showed that the
subunits are related by noncrystallographic 222 (D2) sym-
metry. The structure allows the catalytic site of PGP-I to
be identified and begins to define some key features of
the catalytic mechanism. It serves as a model system to
help elucidate the mechanism of similar enzymes in
higher organisms, including humans. The structure also
allows a detailed comparison of the overall topology and
three-dimensional structure of PGP-I to that of other pro-
teins with similar topology, as well as a comparison of the
organization of the active site with that of other proteases. 
Results and discussion
Description of the structure 
The four independent molecules of PGP-I in the asym-
metric unit are related by three noncrystallographic two-
fold axes so that the resulting tetramer has effective 222
(D2) symmetry (Figure 3). In the last stages of the refine-
ment, only loose noncrystallographic symmetry constraints
were employed (Table 1) and the monomers differ
slightly in the final model. The independent monomers
are designated A, B, C and D (Figure 3). The root mean
square (rms) deviations for all mainchain atoms in residues
20–200 are less than 0.2 Å for all pairwise combinations.
The rms deviations for each pair of monomers are listed in
Table 2. The core structures are in good agreement
among the four monomers of the tetramer. There is a flex-
ible loop region at the N terminus of each molecule and
the conformation of this loop varies between monomers.
Because these loops face the inside of the tetramer and do
not contact symmetry-related molecules, this variation
would not be affected by crystal packing. The central core
regions have substantially smaller rms deviations whereas
the flexible loop regions have larger ones.
The structure of the PGP-I monomer
The PGP-I monomer is shown in Figure 4. The chain folds
into a single α/β globular domain with approximate dimen-
sions of 75 Å × 55 Å × 45 Å. The central core is an α/β
twisted open-sheet with α helices on both sides of the
β sheet. The central sheet comprises four long parallel
β strands (β3, β1, β4 and β8) flanked by two short antipar-
allel β strands (β2 and β5) with –2, +1, +2x, +2, +1 topology
(Figure 4c). The central β sheet is surrounded by five α
helices — two (α2 and α4) on one side and three (α1, α6
and α3) on the other — that run roughly parallel to the β
sheet (Figure 4). A short 310 helix (α5) is located between
α1 and α6, and two short β strands (β6 and β7) form a small
antiparallel β sheet near the beginning of α4 (Figure 4).
The α/β twisted open-sheet structure of the PGP-I core
(comprising β1, β3, β4, β8, α1, α2 and α4) has most of the
defining features of the classic α/β domain [25,26]. These
domains are built of overlapping β-α-β motifs, and in PGP-I
β1-α1-β3, β3-α2-β4 and β4-α4-β8 follow this pattern. The
central β sheet also follows the consensus order 4, 3, 1, 2
with β8, β4, β1, β3. Helices α4 and α2 are on one side of
the sheet and α1 is on the other; this arrangement requires
the connections from the C-terminal ends of two adjacent
β strands to go in opposite directions. In PGP-I, this topo-
logical switch point occurs at the ends of β1 and β3 and
results in a crevice where the active site of proteins con-
taining α/β twisted open-sheets is typically located
(Figure 4). In general, the residues in this central core, with
the exception of the active-site residues, are not well con-
served (Figure 2), although the residues of the four central
strands are almost all hydrophobic. The helices of the core
contain both hydrophobic and hydrophilic residues, and in
general the helices seem to exhibit greater variability than
the strands (Figure 2).
The longest loop in PGP-I occurs between strands β6 and
β7; part of this loop forms an interface with a second
monomer while the rest is exposed to solvent. The loop is
well ordered as judged by its clear electron density and
low thermal parameters (Figure 4b), and the conformation
of the loop in each of the four independent monomers is
essentially identical. The residues from Asn86 to Pro110
at the N terminus of the loop are, perhaps unexpectedly,
well conserved. Asn86, Arg91 and Asp94 are completely
conserved and almost all of the residues of this loop are
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Figure 3
The PGP-I tetramer viewed down one of the noncrystallographic
twofold axes; the monomer pairs A–B and C–D are related by this axis.
Monomer pairs A–C and B–D are related by a vertical
noncrystallographic twofold axis in the plane of the figure and A–D and
B–C are related by a horizontal noncrystallographic twofold axis. The
catalytic triad residues are drawn as space-filling models. Each
monomer is shown in a different color.
conservatively substituted in the PGP-I family (Figure 2).
Residues Asp94–Gly97 form a type II turn, and the main-
chain amino proton of Asn95 forms a hydrogen bond to the
mainchain oxygen of Thr45 at the N terminus of α2
(Figure 4). In addition, one of the oxygen atoms of the
Asp94 sidechain is a hydrogen-bond acceptor for the
amide NH of Glu96 and Asn98. The other oxygen of the
Asp94 sidechain accepts a hydrogen bond from the
sidechain amide NH of Asn98 and the mainchain amide of
Phe47, which is also a conserved residue (Figure 2). Le
Saux et al. noted that an Asp94→Asn mutant of PGP-I
from Pseudomonas fluorescens is not active [27]. Dimer
interactions may also be responsible for the conforma-
tional rigidity of this loop area. Le Saux et al. also reported
that a Glu89(Asp89)→Asn mutant of PGP-I had roughly
25% wild-type activity, whereas Glu89(Asp89)→Ala
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Table 1
X-ray data for PGP-I from Bacillus amyloliquefaciens.
Data set Native 1 †PCMB derivative Native 2
(cocrystallization)
Space group Monoclinic P21 Monoclinic P21 Monoclinic P21
Cell dimensions
a, b, c (Å) 78.71, 80.80, 69.16 78.68, 80.39, 60.07 78.69, 81.15, 69.22 
β (°) 92.8 92.8 92.6
No. of molecules/asymmetric unit 4 4 4
Solvent content (%) 49 
Vm (Å3/Da) 2.3 
Resolution (Å) 15.0–2.0 15.0–2.5 15.0–1.6
Rsym (multiplicity) 6.0 (2.3) 5.8 (3.9) 5.5 (2.0)
Completeness (%) 84.4 86.9 81.0
Rmerge 0.055*
Phasing power 1.845
Phasing power (anomalous) 1.645
Figure of merit 0.524
Figure of merit (NCS averaging) 0.791
Protein atoms in the final model
(4 × 1 ~210 residues) 7400
No. of water molecules 325
No. of unique reflections used 
for refinement 83,443 (F≥2σ(F))
NCS refinement restraint
for mainchain (20–200)(kcal/mol Å2) 10
Rcryst (%) 21.6
Rfree (%) 26.0
Rmsd
bond lengths (Å) 0. 011
angles (°) 2.21
Ramachandran plot statistics
Residues in most favored region (%) 90.8
Residues in disallowed regions Tyr48A, Tyr48B, Tyr48C, Tyr48D
Average B factor
mainchain 18.4
sidechain 22.5
*For 15.0–3.0 Å resolution data. †PCMB, p-chloromercuribenzoic acid.
Table 2
The root mean square deviations for each PGP-I monomer.
Monomer Mainchain (Å) All atoms (Å) Mainchain (Å) All atoms (Å)
(1–210) (1–210) (20–200) (20–200)
A–B 0.23 0.87 0.11 0.86
A–C 0.31 0.99 0.13 0.96
A–D 0.43 0.47 0.16 0.97
B–C 0.29 0.86 0.12 0.81
B–D 0.36 0.92 0.12 0.82
C–D 0.28 0.79 0.11 0.74
mutant had no measurable activity (Figure 2) (where the
residue number in parentheses refers to B. amyloliquefa-
ciens, otherwise the residues are for P. fluorescens [27]).
Residue 89 is conservatively substituted with either aspar-
tate or glutamate. In the crystal structure, Glu89 makes a
salt bridge with Arg82 and Lys120 of an adjacent PGP-I
molecule, and both Arg82 and Lys120 are conserved. Pre-
sumably this intermolecular interaction would be tolerant
of an aspartate to glutamate change, and in addition to
their contributions to dimer stabilization (see below), they
could also help position Glu81 in the catalytic triad. The
conserved residues, rigidifying hydrogen-bonding pattern,
and the dimeric interaction in this region appear to be
important for PGP-I activity.
The structure of the PGP-I tetramer
The PGP-I tetramer observed in the crystal is a 75 Å cube
with an elliptical 20 Å × 10 Å channel running through the
center of one pair of opposite faces; the noncrystallographic
twofold axis relating A to B and C to D runs through the
center of this channel (Figure 3). Each monomer forms
extensive contacts with two other monomers in the
tetramer, and interacting monomers are related by noncrys-
tallographic twofolds axes in the contact regions (Figure 3).
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(a)
(c)
(b)
The monomeric subunit of PGP-I from B. amyloliquefaciens.
(a) Ribbon diagram of PGP-I. Catalytic residues are shown and
secondary structure elements are labeled. (b) Stereo diagram of 
PGP-I. Ribbon elements are colored according to B factor: residues
with B factors below 10 Å2 are in dark blue and residues with B factors
above 30 Å2 are in bright red. The figure was produced using the
programs BOBSCRIPT, MOLSCRIPT [62] and RASTER3D [63].
(c) Topological representation of PGP-I. The letters C, H and E
represent the catalytic residues Cys144, His168 and Glu81,
respectively. The boxed region, highlighted with a dashed line,
encompasses elements of the α/β structure.
The A–D interaction involves the long loops between β
strands β6 and β7 (Figure 3). This interaction buries
1427 Å2 of primarily hydrophobic surface [28], although
apparent salt bridges are found between Arg82A–Glu89D,
Glu89A–Lys120D and the noncrystallographic symmetry-
related Arg82D–Glu89A and Glu89D–Lys120D pairs
(Figure 5). Arg82 is a conserved residue; Glu89 and Lys120
are conservatively changed to aspartate and arginine,
respectively, in the PGP-I family (Figure 2). Other than
the salt bridges, hydrophobic contacts dominate the A–D
interaction. Ile85, Asn86, Leu87, Ala111, Ala112, Trp114,
Tyr137, Thr138 and Thr141 are all involved in hydropho-
bic interactions and have close contacts (< 4.0 Å) with the
nearest atoms of the adjacent monomer. These residues
are well conserved (Figure 2). 
The A–C interaction uses the 310 helix (α5) and the loop
between helices α5 and α6. This interaction buries 1355
Å2 of primarily hydrophobic surface [28]. Met76, Ile131,
Pro132, Pro173, Thr176, Leu177, Ala181, Pro182 and
His188 are involved in hydrophobic interactions with dis-
tances of less than 4.0 Å to the adjacent monomer. The
A–C interaction is less extensive than the A–D inter-
action in that it buries less hydrophobic surface and forms
no salt bridges. The A–C interaction also features a thin
well-ordered (low B factor) water layer between the
monomers. This water layer covers almost one-third of
the A–C interface, and some of the hydrogen bonding
between A and C is mediated by water molecules.
Neither interaction region involves mainchain hydrogen
bonding between the monomers, although some
sidechain hydrogen bonds are observed. 
The observed tetrameric structure of PGP-I does not com-
pletely clarify the state of aggregation in solution. Gel filtra-
tion indicates a solution homodimer for B. amyloliquefaciens
PGP-I, suggesting that one of the two different
monomer–monomer interactions dominate in solution and
that the other is a minor interaction or an artifact of crystal-
lization. On the basis of the more extensive interaction area
and the involvement of conserved residues, an A–D solu-
tion interaction is favored. Nevertheless, the PGP-I from
Bacillus subtilis, which has 72% identity (85% similarity;
Figure 2) with PGP-I from B. amyloliquefaciens, exists as a
homotetramer in solution [10,29–31]. The A–C interaction
may, therefore, be relevant to the solution structures of
some PGP-I family members. Human PGP-I is reported to
be active as a monomer [10,32–34]. 
The active site, which is described below, is contained
entirely within a monomer and is on the exposed face of
the channel running through the tetramer (Figure 3).
Thus the structure suggests that PGP-I could be catalyti-
cally active as a monomer, dimer or tetramer and the con-
sequences of aggregation on PGP-I activity will require
further study.
The crystal structures of two serine proteases that have a
similar quaternary structure with a central channel and
222 tetramer symmetry have been reported— PR3, an elas-
tase like enzyme, and tryptase [35,36]. The family of pro-
teases with 222 tetramers in the solid state therefore has at
least three members. The topology of the monomer struc-
ture differs between these two enzymes and PGP-I — PR3
and tryptase belong to the chymotrypsin family. Despite
these differences, the quaternary structures of all three
enzymes are quite similar with the active site of each pro-
tease facing towards a central channel. Tryptase is reported
to be active only as the tetramer [36]. As the substrates of
PGP-I are small peptide hormones, and the size of the
central channel of PGP-I is larger than the substrates, it is
possible that PGP-I could be active in the tetrameric form.
Larger substrates or intrinsic inhibitors may not be accom-
modated in the central channel leading to the active site,
and the 222 symmetric tetramer may be important for reg-
ulating the activity of PGP-I.
The active site
The active sites of cysteine and serine proteases are typi-
cally characterized by a catalytic triad or diad, an oxyanion
hole and specificity pockets. As PGP-I loses activity when
treated with a standard cysteine protease inhibitor,
PCMB, it has been assumed to be a cysteine protease
[17,20]. The PGP-I from B. amyloliquefaciens has two cys-
teine residues, Cys68 and Cys144, and both are located in
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Figure 5
The final 2Fo–Fc electron density around the active site. The final
protein model is shown as a stick figure. Cys144 is on the right-hand
side, His168 is in the middle and Glu81 is above His168. The map is
contoured at the 1.0σ level; atoms are shown in standard colors. (The
figure was prepared using the program O [64].)
the hydrophobic core. Cys144 is completely conserved
(Figure 2) in all known PGP-I sequences and occurs at the
N terminus of α4 (Figure 4). The other cysteine, Cys68, is
located in the middle of β4, and the corresponding residue
is alanine in some PGP-I sequences. The catalytic role of
Cys144 has been most clearly demonstrated by site-
directed mutagenesis studies: a Cys144→Ser PGP-I
mutant is not active, whereas Cys68→Ser has wild-type
activity [17]. A nucleophilic Cys144 is also compatible
with the general location of active-site residues in the
topological switch region of twisted open-sheet α/β struc-
tures (Figure 4). The chain of the PGP-I monomer folds
into an α/β structure with the central β sheet surrounded
by α helices. In the PGP-I structure, the nucleophilic
Cys144 is at the N terminus of an α helix, as are the nucle-
ophilic cysteines in the papain/cathepsin family. In the
α/β-hydrolase fold, a typical α/β structure, the nucle-
ophilic serine is on a sharp turn in a loop from a β strand to
an α helix. PGP-I follows the general α/β-structure
pattern, but the nucleophile occupies a different position
from that of other α/β-hydrolase fold enzymes. Of course
the location of the nucleophile at the N terminus of an α
helix could have important consequences for catalysis, as
the helix dipole can polarize the amide bond and enhance
its reactivity [37]. 
His166 had also been implicated in the active site, and the
His166→Ala mutant from PGP-I P. fluorescens is inactive
[36]. The sidechain sulfhydryl of Cys144 forms a hydrogen
bond with His168, which is near the C terminus of β8. In
the different monomers of the tetramer, the distance
between Cys144 Sγ and His168 Nδ1 ranges from 3.4 Å 
to 3.6 Å. Finally, site-directed mutagenesis studies have
implicated some acidic residues in PGP-I catalysis. 
The PGP-I mutants Glu81→Gln, Asp89(Glu89)→Ala,
Asp89(Glu89)→Asn and Asp94→Asn (Figure 2; where
residue numbers in parentheses refer to P. fluorescens) are
either totally inactive or their activity is dramatically
diminished in comparison to the wild-type enzyme [36].
Only Glu81, which is on the loop from β5 to β6, is in a
position to form the third member of a Cys144-His166-
Glu81 catalytic triad. No activity can be measured for the
Glu81→Gln mutant of PGP-I [36]. In the structure, a
nitrogen atom in the sidechain of His168 forms a hydrogen
bond to Glu81 with Nε to Oε distances of 2.7 Å to 2.8 Å in
the different monomers. Although the Cys-His-Glu 
catalytic triad of PGP-I appears conventional, neither its
linear sequence (Cys, His, Glu) nor its three-dimensional
arrangement are compatible with the known cysteine 
proteases (Table 3).
In PGP-I, there does not appear to be a well defined
oxyanion hole, at least not  in the traditional sense of a
hole comprising two mainchain NH hydrogen-bond
donors, as in chymotrypsin [38,39], in PGP-I. In papain,
the crystal structure and site-directed mutagenesis studies
indicate that a sidechain amide NH of a glutamine residue
contributes to the oxyanion hole [40,41]. One likely con-
tributor to the stabilization of the tetrahedral oxyanion is
the mainchain NH on Cys144; the other could be a
sidechain NH from Arg91, which lies within a highly con-
served region of PGP-I (Figure 2). As discussed previ-
ously, this loop region around Arg91 is highly conserved
and firmly held by intermolecular and intramolecular
interactions. In the native structure, the Nε atom of Arg91
is 6.8 Å away from Sγ of Cys144, but substrate binding
could easily cause some displacement. 
A hydrophobic binding pocket that would function nicely
as an S1 site for pGlu is found near Cys144 (Figure 6a).
The pocket comprises Phe10, Phe13, Thr45, Ile92,
Phe142, Val143; all of these residues are well conserved
(Figure 2). The sidechain methylene of Gln71 also con-
tributes to this pocket and the sidechain of this residue is
oriented through a pair of tight hydrogen bonds with
Gln175. The S1 pocket thus appears to have some confor-
mational flexibility. In comparing the four independent
monomers, the sidechain conformations of some residues,
especially Phe13, differ. As there are relatively large con-
formational differences in the loops containing contribu-
tors to the S1 pocket, noncrystallographic symmetry
restraints are omitted for residues 1–20. In the structure,
water molecules are located in the S1 site: one molecule in
each of the monomers B, C and D and two in monomer A.
PGP-I does not appear to have any other clearly defined
specificity pockets, which is consistent with PGP-I’s lack
of substrate specificity.
Modeling substrate binding
In order to judge the feasibility of our substrate-binding
analysis, the N-terminal dipeptide of TRH, a pGlu–His
model, was manually placed in the PGP-I-binding pocket
and adjusted through a molecular dynamics simulation
using Charmm/QUANTA [42]. A stereoview of the final
model is presented in Figure 6b. Two methylene carbon
atoms of the γ-lactam point to the bottom of the putative
S1 site and the lactam itself is held between the aromatic
ring of Phe13 and the methylene chain of Gln71, with the
lactam carbonyl pointing away from the pocket. The pGlu
mainchain carbonyl forms a hydrogen bond with the
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Table 3
Sequence order of catalytic triad residues for serine and
cysteine proteases.
PGP-I Glu81 Cys144 His168
ICE* [22,23] Pro177(CO) His237 Cys285
Picornaviral 3C [21] His4 Asp84 Ser172
Papain [20] Cys25 His159 Asn175
Cutinase [45] Ser120 Asp175 His188
*ICE, interleukin-1β converting enzyme. The table lists the residues
involved in the catalytic triad of five serine and cysteine proteases and
gives their relative positions.
guanidino group of Arg91 (Figure 6b). The imidazole
nitrogen of the histidine sidechain hydrogen bonds with
the mainchain amide proton of Thr141. PGP-I is not
selective for residues in the second position, and groups
with variable charge, hydrophobicity and size are accom-
modated [10]. The residues that interact with the histi-
dine sidechain in the model are not charged. The carbonyl
oxygen of the C-terminal oxygen of the model also forms a
hydrogen bond to Gly73 NH in a parallel β-sheet fashion.
The residues that interact in the model are listed in
Table 4 and, as can be seen in Figure 2, the residues that
interact with pGlu are well conserved. The residues that
interact with the third residue are also suggested by the
model. The molecular surface where the second and third
residues would interact is a relatively flat groove running
out of the active site. Residues of longer peptides, such as
gastrin, are likely to bind in this groove and form hydrogen
bonds in a parallel β-sheet fashion with the loop connect-
ing β4 to β5. Some residues in the groove region are con-
served (Gly74 and Arg75) or conservatively substituted
(Thr/Ser79), but the degree of conservation does not
nearly approach that of the putative S1 site.
Structural similarities with other proteins
As PGP-I shows no significant sequence homology with
other proteins, its structural classification was approached
through an alignment of distance matrices using the
program DALI [43]. The best fit (Z score = 12.1) is with
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Figure 6
The PGP-I active site. (a) Stereo diagram of
the active site of PGP-I. Catalytic residues are
drawn in a ball-and-stick convention. The
residues shown in blue stick representation
comprise the S1 pocket. Arg91, which is
believed to contribute to the stabilization of
the tetrahedral intermediate, is shown as a
pale blue stick figure. (b) Putative PGP-I
complex with a pGlu–His model; the model is
shown in ball-and-stick representation. The
van der Waals surface of PGP-I was
generated with GRASP [25] and is shown in
red net representation. (The figure was made
with the program RASTER3D [63].)
purine nucleoside phosphorylase (PNP, EC 2.4.2.1) [44].
PNP has 237 residues, almost the same number as PGP-I.
The secondary structure of PNP (Figure 7a) is essentially
identical to that of PGP-I except for the short 310 helix
(α5) and the antiparallel β strands at the beginning and
end of the long loop (β6 and β7). All five helices superim-
pose nicely in direction and position, and the central β
sheet, strands β3 to β5, also superimpose well (Figure 7a).
The major differences are the long loop in PGP-I and the
extra β strand between α1 and β2 in PNP (Figure 7a).
Brändén [25,26], suggested that α/β proteins are well
suited topologically to form binding crevices at the
carboxy end of the sheet where the strand order switches,
and the substrate-binding sites of PGP-I and PNP are in
this location. The catalytic residues of these two proteins
have very different orientations, however, and the striking
structural similarity probably arises from general principles
governing protein structure, rather than an evolutionary
relationship. There are several other proteins with strong
structural resemblances to PGP-I — other PNP family
members, the metalloproteases, leucine amino peptidase
and carboxypeptidase — but the structural similarity does
not appear to add much to our understanding of PGP-I.
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Figure 7
Comparisons of PGP-I with related structures.
(a) Ribbon diagrams of PGP-I and PNP.
(b) Ribbon diagrams of PGP-I and cutinase.
The regions of topological consensus are
shown in red and regions lacking topological
consensus are shown in gray. The catalytic
residues are shown in ball-and-stick
representation (see text for full discussion).
Table 4
Residues that interact with sidechain atoms (distance < 4.0 Å)
of the model dipeptide.
pGlu–His pGlu His X
PGP-I Phe13 Thr141 Ala72
Glu16 Phe142 Gly73
Asn19 Val143 Gly74
Gln71 Cys144 Arg75
Asn145 Phe171
His168
Gln175
The residues that interact with pGlu and histidine are given in the first
two columns. The third column lists residues that are likely to interact
with the first residue of a pGlu–His–X peptide.
One of the most informative matches (Z score = 3.8) is
that obtained for the cutinase from Fusarium solani [45].
Cutinase is a lipolytic enzyme that hydrolyzes triglyc-
erides and degrades the lipid polyester matrix covering
the surfaces of plants. Cutinase has a central β sheet with
five parallel strands and five helices on both sides of the
sheet. The fold of cutinase is similar to that of lipase 
and, more generally, to that of the α/β-hydrolase fold
(Figure 7b). The active site of cutinase contains the cat-
alytic triad Ser120, which is located at the carboxy end of
the topological switch point, His188 and Asp175. Ser120 is
located at the N terminus of an α helix in a position equiv-
alent to that of the Cys144 residue of PGP-I. In spite of
the similarity of the three-dimensional structures and the
existence of a catalytic triad, there are important differ-
ences. The order of the catalytic triad is Ser-Asp-His not
Asp-Ser-His, and the three-dimensional arrangement is
completely different. As the linear order (Table 3) and
three-dimensional arrangement are the most conserved
features of the proteases [20], the resemblance of cutinase
and PGP-I is unlikely to have an evolutionary basis.
Biological implications
Peptides are widely used to carry biological information
from one location to another. A peptide hormone, such as
thyrotropin-releasing hormone (TRH), carries informa-
tion within an organism from one cell to another. Simi-
larly, a probable defensive peptide, such as bombesin,
carries information —get lost! —from the skin of an
amphibian to its would be predator. If the peptide is
degraded while on route, the message is lost; peptide mes-
sengers therefore have the ability to resist most proteases.
Both TRH and bombesin have an N-terminal pyroglu-
tamyl residue that resists attack by aminopeptidases. Spe-
cialized proteases are then used by the producer of the
peptide messenger to turn off the message or by predators
to subvert the flow of information. Two types of pyroglu-
tamyl peptidase (PGP) are known: PGP-Is, proteases
with a broad spectrum of activity, and PGP-II, a protease
with narrow TRH specificity. PGP-II is used by the
TRH producer to turn off the TRH message, and PGP-I
is used by an organism wishing to subvert the TRH
message. Recent work suggests that the ability of PGP-I
to degrade TRH could be a component of a bacterial sur-
vival strategy. The large surface area of the human
intestinal mucosa facilitates the absorption of nutrients,
but its single layer of cells must also exclude infectious
agents. One defense strategy of the gut employs TRH to
send signals to immune cells, and TRH is emerging as an
important feature of intercellular communication. PGP-I,
with its ability to degrade TRH, could thus be a weapon
for would be invaders. 
The crystal structure of PGP-I reported here is the first
for this class of enzymes. The structure explains the
roles of the conserved residues, identifies the active site,
and elucidates the similarities and differences between
this and other proteases.
Materials and methods
Protein purification and crystallization
The expression and purification of PGP-I from B. amyloliquefaciens has
been described previously [17]. Crystallization conditions have also
been reported [17], but do not provide crystals that diffract to high reso-
lution. Crystallization conditions were searched again using a crystal
screen kit [46] to give a different crystal form. The crystallization of PGP-
I was performed at pH 6.5, 0.05 M sodium cacodylate/KH2PO4 buffer
with 0.1 M magnesium acetate, using 10% w/v polyethylene glycol
(PEG) 4000 as precipitant. The protein concentration was 7mg/ml.
Crystals were obtained in two or three weeks and had a pentagonal
column morphology with average dimensions of 0.3 × 0.3 × 0.4 mm3.
Crystals form in the monoclinic space group P21 with cell constants
a = 78.71, b = 80.80, c = 69.16Å and β = 92.75° and diffract to better
than 2.0 Å resolution. The monoclinic unit cell contains eight molecules
of PGP-I, four per asymmetric unit, with a solvent content of 49%. A 
p-chloromercuribenzoic acid (PCMB) derivative with cell constants of
a = 78.68, b = 80.39, c = 69.07Å and β = 92.75° was obtained by
cocrystallization. The derivative also diffracts to 2.0 Å resolution and
later analysis showed that the PCMB bound to Cys144.
Data collection
Native and PCMB derivative data were collected at 20°C on a San
Diego multiwire system (SDMS) Mark III multiwire area detector [47,48],
mounted on a Rigaku rotating anode operating at 50 kV and 150 mA.
SMDS software was used for data collection and SCALEPACK [49]
was used for processing. The native data set is 84.4% complete
between 15.0 and 2.0 Å with an Rsym [45] of 6.0% and a multiplicity of
2.3. The PCMB data set is 86.9% complete between 15.0 and 2.0 Å
with an Rsym of 5.8% and a multiplicity of 3.7. The completeness of the
crystal used for the final refinement is 81.0% with an Rsym of 5.5% and
multiplicity of 2.0 between 15.0 and 1.6 Å. These data were also col-
lected using an SMDS Mark III/ Rigaku generator. 
Structure solution
The structure of PGP-I was determined by single isomorphous
replacement with anomalous scattering (SIRAS) on a PCMB derivative
combined with noncrystallographic symmetry (NCS) averaging
(Table 1). Scaling of native and derivative data, Patterson calculation,
heavy-atom refinement, noncrystallographic symmetry averaging and
electron-density map calculations were performed using the programs
available in the PHASES package [50]. R merge between the native
data and the PCMB derivative data was 5.5% for 3.0 Å resolution
data. The phasing power was 1.845 and the mean figure of merit was
0.524. The protein phases were improved by noncrystallographic sym-
metry averaging (222 symmetry), using the protocol implemented in
the PHASES package. The POLARRFN from the CCP4 suite [51] cal-
culation revealed two of the twofold axes and suggested the existence
of another with almost the same direction as the crystallographic b
axis. The positions of the axes were deduced from the heavy-atom
positions. It was not possible to make proper masks for each
monomer, because of the noise in the map and the tight contacts
between the monomers. Firstly, four simple spheres were prepared as
the masks, centered on the heavy atoms and having a 24 Å radius. The
radius value came from the distance between heavy atoms. MDLMSK
in the PHASES package was used for creating the masks from the
coordinates of the heavy atoms and LSQROTGEN was used for the
refinement of local symmetry axes. The deviations from a strict 222
symmetry are less than 1.6°. After the averaging calculation, the figure
of merit improved to 0.791. During the model building, the masks were
rebuilt for further averaging calculations.
Model building and refinement
Electron-density maps were displayed and model coordinates were fit
on a Silicon Graphics workstation using the interactive computer
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program CHAIN [52]. We could not assign the five C-terminal amino
acid residues because of disorder.
The final model is the result of alternate cycles of manual rebuilding and
refinement using the X-PLOR simulated annealing protocol [53]. For the
final refinement, another crystal was used that diffracts up to 1.6 Å. The
dimensions of the crystal were almost 1 mm3 and the bulk-solvent mask
procedure was indispensable for a good result, because of the composi-
tion of the crystallization solution. In the initial cycles, tight noncrystallo-
graphic symmetry constraints were applied; in later cycles the constraints
were weakened or, in the case of the flexible loop regions between the
N terminus and α1 including β1, omitted. After several rounds of refine-
ment, model building and individual B-factor refinement (using 2σ data
from 15.0–1.6 Å resolution, 83,443 reflections) we arrived at a final
model with an Rcryst of 21.7% and Rfree of 26.0% (calculated for a ran-
domly selected 10% subset of reflections not used in the refinement).
Rms deviations from ideality were 0.011 Å and 2.21°, for bond lengths
and bond angles, respectively. During the final stages of refinement, water
molecules were inserted into the model only if there were peaks in the
|2Fo–Fc| maps with heights larger than 2.0σ within hydrogen-bonding dis-
tance of appropriate atoms (Table 1). Water molecules with a tempera-
ture factor greater than 70 Å2 were excluded from subsequent steps. The
final model includes residues 1–210 and 315 water molecules, the five
C-terminal residues and the sidechains of a few residues at the C termi-
nus are not visible in electron-density maps. Figure 5 shows the final
|2Fo–Fc| map around the active-site residues calculated using the final
model and 1.6 Å resolution data. A PROCHECK [54], assessment of the
quality of the final structure showed over 90% of the residues falling in the
most favored region of the Ramachandran plot and no cis peptide bonds.
The mainchain conformation of Tyr48 of each monomer does not
satisfy the Ramachandran plot [54], but doing so would involve clashes
with symmetry-related molecules. The distance between Cε1 of Tyr48
and the symmetry-related Cγ of Asp205 is 3.4 Å.
Accession numbers
The coordinates of PGP-I have been deposited with the Brookhaven
Protein Data Bank under the entry code 1AUG.
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